Total Funding
39
32
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
239945
Atheric Pharmaceutical LLC ("Atheric(tm)") is a biopharmaceutical company focused on the rapid development and commercialization.
- Jeffrey DiFrancesco: Co-FounderPast Role: Savera Systems Inc., Chief Financial & Operating Officer
- Diego Mezzogiorno: Senior International Consultant
About the Company
Atheric™ Pharmaceutical LLC is a biopharmaceutical company focused on the rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus disease. Atheric's lead drug products are reformulated broad spectrum antiviral drugs that inhibit autophagy-dependent viral replication as well as other
anti-viral pathways. Atheric is committed to providing broad-spectrum medical countermeasures for Zika and other neglected tropical diseases.
